PHV 2017 - 14th Pharmacovigilance 2017

The Pharmacovigilance conference, organised yearly by Virtue Insight, is a unique event where key stakeholders gather with the aim of promoting patient safety and undertaking to continue work towards a more efficient pharmacovigilance system. In the spirit of constructive cooperation, this event brings together representatives from the industry and regulators as well as healthcare professionals and patient organisations.
In order to succeed in this new environment, it is critical to be up to date on legislation globally and be transparent in all PV process. We need to have effective systems in place to empower patients, physicians, drug manufacturers and consumers to make the best drug safety decisions.
14th Pharmacovigilance 2017 will bring together key thought leaders and experts to explore these worldwide challenges. This is your opportunity to engage and sit alongside the pioneers who are driving forward innovation in pharmacovigilance. Explore benefit-risk management strategies and patient-centric approaches; discuss how you can tackle the challenges of social media and drug safety legislation globally.
Morning sessions reflect on achievements so far and focus on the milestones ahead. An open dialogue between key stakeholders has proven to be the right approach for making significant progress towards better pharmacovigilance for better public protection. Traditional afternoon brainstorming sessions stimulate a lively, engaging debate incorporating all perspectives. Hot topics are debated to identify the best possible processes and tools leading to better access to high quality medicines in India.
It gives us immense pleasure in welcoming you to the 14th Pharmacovigilance 2017
KEY THEMES DISCUSSED AT THIS CONFERENCE:-
PV legislation: What are the next steps? Reflections from the commission, IMA and the industry.
How to improve pharmacovigilance activities?
Creating a PV-focused culture
How can you achieve pragmatism environment in today's PV?
Pharmacovigilance and enabling technologies: which business model in a fast changing world?
Opportunity that can reduce financial risk and increase effectiveness
Pharmacovigilance Inspection Readiness
Risk Minimization and effectiveness evaluation
Business partners and exchange of safety data
Optimising Drug Safety through Research Based Pharmacovigilance
Launching a digital app in India for reporting ADRs: first results
PV automation for data processing - Can Artificial Intelligence be trusted
How social media can be used for pharmacovigilance syste
Barriers to adopting AI and automation
Patient view: the influence of real-time patient ratings and reviews of medicines and healthcare, and how this will shape the future of pharmacovigilance
Proactively accomplish drug safety through patient engagement
The challenges of the Indian Regulation – How to adapt and when?
Required undergo registration process with CDSCO & DCGI
Accelerating new medicine introduction in developing world & overcoming challenges
Be part of a major networking opportunity